Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWegovy (semaglutide 2.4mg) is a prescription-only medicine in the UK, which means a qualified prescriber must assess you clinically before any treatment can be dispensed. There is no legal route to obtain it on prescription without that assessment. The process is more straightforward than many people expect: a consultation, a clinical review, and if approved, dispensing through a GPhC-registered pharmacy. Wegovy is licensed for adults with a BMI of 30 or above, or 27 or above alongside a weight-related health condition such as high blood pressure or type 2 diabetes. Because it is a Prescription-Only Medicine, a prescriber decides suitability based on your individual health picture — a BMI figure alone does not guarantee approval.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The first step is a structured health consultation. For a private online prescription this happens through a regulated service, you answer questions covering your weight history, current health conditions, medications and relevant lifestyle factors. This is not a formality. The clinical information you provide is what a prescriber uses to judge whether Wegovy is appropriate for you specifically, and whether anything in your history (certain gastrointestinal conditions, a history of pancreatitis, pregnancy, or specific medications) would make it unsuitable.
At nume, every consultation is personally read by a GPhC-registered Independent Prescriber the same day. A real clinician reviews your answers, not an automated system. If you submit before noon on a working day, your prescription decision arrives the same day.
You can find out more about what the consultation covers on our guide to getting approved for Wegovy, or read about the wider semaglutide prescribing process on the semaglutide prescription page.
UK regulations require that a prescriber can be confident they are treating the person who filled in the consultation. Reputable services (any you would trust with a prescription medicine) carry out photo-ID verification and live weight confirmation. At nume this happens via a short video step, which takes only a few minutes.
This is worth knowing about before you start, partly because it is a mark of a legitimate service. If a seller asks for none of this, that is a red flag. The MHRA has issued repeated public warnings about counterfeit weight-loss pens sold through social media channels and unverified websites, and fake pens seized in enforcement operations have on occasion contained insulin rather than semaglutide. Checking the GPhC register before you hand over any personal or payment information is a quick habit: the register is searchable by name or registration number, and a legitimate UK online pharmacy will appear there within seconds.
Our online Wegovy prescription guide walks through what to expect during verification.
Once a prescription is issued, your treatment is dispensed by a GPhC-registered pharmacy and dispatched. Medicines must travel through the licensed UK supply chain, at nume that means sourcing from authorised Novo Nordisk distributors. This matters because it is the only way to be confident the pens are genuine, stored correctly throughout their journey, and within their licensed temperature range.
Wegovy pens require refrigeration. Your delivery should arrive in temperature-controlled packaging, and your pen should go straight into the fridge on arrival. The patient information leaflet sets out the exact room-temperature window if you need to take it out temporarily, it is worth keeping a copy to hand.
On the question of Wegovy pricing in the UK, it is reasonable to compare providers, but the cheapest listing is not always the safest bet for a prescription medicine. What matters is that the service includes a genuine clinical review, a verified supply chain, and proper aftercare if questions arise after you start.
After dispatch, prescription decisions do not end. At nume (sorry, at nume) each repeat order triggers a fresh clinical review before anything ships. No automatic renewals.
Wegovy is available on the NHS, but access is rationed by strict NICE criteria. NICE's appraisal of semaglutide (TA875) recommends it only within a specialist weight management service, for adults with a BMI of 35 or above (or 30–34.9 under certain referral conditions) and at least one weight-related comorbidity, and for a maximum of two years. Waiting times through NHS specialist services can be long, and not every area has consistent access.
Private routes exist precisely for people who do not meet the NHS criteria, do not want to wait, or prefer the convenience of an online service. The prescription process described above is the private route. You can read a fuller comparison of NHS and private access on our how to get a Wegovy prescription page, or explore what treatment involves more broadly on our weight-loss treatment overview.
If you are ready to find out whether Wegovy is clinically suitable for you, you can speak to our prescribers by starting a free consultation at our treatment page.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.